IGHE and schistosomiasis: It has been suggested that a vaccine activating macrophage-induced Th1 cytokines (IFN-γ and IL-2) may help in the prevention of schistosomiasis and, although the mechanism is unclear, an IgE antibody-dependent targeted cellular cytotoxicity has also been shown to protect humans.